Product category:
Microprocessors, Microcontrollers and DSPs
News Release from: AMI Semiconductor
Edited by the Electronicstalk Editorial
Team on 28 November 2006
Cochlear signs for medical SoC design
Cochlear has selected AMI Semiconductor AMIS as its semiconductor co-design and manufacturing partner for its future generation DSP-based SoC.
Cochlear has selected AMI Semiconductor AMIS as its semiconductor co-design and manufacturing partner for its future generation DSP-based SoC Cochlear implants are a proven treatment for severe-to-profound hearing loss in adults and children
This article was originally published on Electronicstalk on 26 Mar 2001 at 8.00am (UK)
Related stories
Clock generators for embedded communications
AMI Semiconductor (AMIS) has expanded its clock generator product line with a broad family of low-cost 1- and 2-phase-lock loop (PLL) clock ICs.
Clock generator saves space in portable designs
AMI Semiconductor (AMIS) has introduced a low-cost clock generator that will save space and reduce component count in high-performance MPEG-2 applications such as DVD players.
The surgically implanted electronic device bypasses damaged hair cells and stimulates the hearing nerve fibres directly inside the cochlea, providing useful hearing and improved communication abilities to the wearer.
External components include a sound processor and transmitter that relay processed signals to the implant using electromagnetic induction.
Placed under the skin behind the ear, the implanted components include a receiver and an electrode-array that is placed into the cochlea to stimulate precise locations on the auditory nerve.
Cochlear's current generation Nucleus Freedom system was approved by the US Food and Drug Administration (FDA) in March 2005 and is implanted in over 12,000 patients worldwide.
"Technical leadership and continually advancing the hearing performance, reliability and usability of our devices is fundamental to our strategy", said Jan Janssen, Senior Vice President of Design and Development at Cochlear.
"With proven expertise in advanced mixed-signal technologies, deep knowledge of audiological technical requirements and a solid body of existing semiconductor IP, we chose AMI Semiconductor as a technology partner".
"We believe that with the help of AMIS, we will introduce new capabilities, offering an enhanced quality of life for people with severe to profound hearing loss".
"We are thrilled to form a technology partnership with Cochlear".
"Their track record of innovation is truly impressive", said Todd Schneider, Vice President of the Medical Group at AMIS.
"Cochlear implants continue to be the largest segment of the neural prostheses category of neurostimulation medical devices and an area where we've developed specific expertise and innovative solutions".
"This relationship reinforces our belief that customers value a dependable and highly flexible partner dedicated to meeting the specific semiconductor needs of the medical device market".
• AMI Semiconductor: contact details and other news
• Email this article to a colleague
• Register for the free Electronicstalk email newsletter
• Electronicstalk Home Page
Search the Pro-Talk network of sites
